White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

Body fluid biomarkers have great potential for different clinical purposes, including diagnosis, prognosis, patient stratification and treatment effect monitoring. This is exemplified by current use of several excellent biomarkers, such as the Alzheimer’s disease cerebrospinal fluid (CSF) biomarkers...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Teunissen, Charlotte E., Otto, Markus, Engelborghs, Sebastiaan, Herukka, Sanna-Kaisa, Lehmann, Sylvain, Lewczuk, Piotr, Lleó, Alberto, Perret-Liaudet, Armand, Tumani, Hayrettin, Turner, Martin R., Verbeek, Marcel M., Wiltfang, Jens, Zetterberg, Henrik, Parnetti, Lucilla, Blennow, Kaj
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5855933/
https://ncbi.nlm.nih.gov/pubmed/29544527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0359-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados